Skip to main content

06-11-2016 | Advanced breast cancer | Article

Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2–Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study

Perez EA et al. J Clin Oncol 2017; 35(2): 141-148. doi:10.1200/JCO.2016.67.4887

Please log in to get access to this content

Related topics

Breast cancer in the 2020 ASCO Virtual Scientific Program

All the news and expert video interviews from the virtual meeting

Image Credits